Takeda Pharmaceutical Co Ltd/ US8740602052 /
| 9/11/2024 9:59:58 PM | Chg. -0.07 | Volume | Bid9:59:58 PM | Ask9:59:58 PM | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 14.82USD | -0.44% | 45,271 Turnover: 669,519.06 |
14.80Bid Size: 1,400 | 14.82Ask Size: 1,400 | 46.11 bill.USD | - | - |
Fundamentals
| FY 2023 | Growth (1Y) | |
|---|---|---|
| Per Share | ||
| Earnings per Share: | 204.29 JPY | 38.84% |
| EPS Diluted: | - JPY | - |
| Revenues per Share: | - JPY | - |
| Book Value per Share: | - JPY | - |
| Cash Flow per Share: | - JPY | - |
| Dividend per Share: | - JPY | - |
| Total | in mill. | |
| Revenues: | 4,027,478.00 JPY | 12.85% |
| Net Income: | 317,017.00 JPY | 37.80% |
| Operating Cash Flow: | 977,156.00 JPY | - |
| Cash and Cash Equivalents: | 533,530.00 JPY | - |
Valuation Ratios
| Current | Latest FY* | |
|---|---|---|
| P/E Ratio: | - | - |
| P/S Ratio: | - | - |
| P/BV ratio: | - | - |
| P/CF Ratio: | - | - |
| PEG: | - | - |
| Earnings Yield: | - | - |
| Dividend Yield: | - | - |
| Market Capitalization | ||
| Market Capitalization: | 46.11 bill. USD | 48.82 bill. USD |
| Free Float Market Cap.: | - USD | - USD |
| Market Cap. / Employee: | - USD | - USD |
| Shares Outstanding: | - | |
Profitability
| Gross Profit Margin: | 69.11% |
| EBIT Margin: | 12.18% |
| Net Profit Margin: | 7.87% |
| Return on Equity: | 4.99% |
| Return on Assets: | 2.27% |
Financial Strength
| Liquidity I / Cash Ratio: | 21.50% |
| Liquidity II / Quick Ratio: | 47.66% |
| Liquidity III / Current Ratio: | 96.62% |
| Debt / Equity Ratio: | 119.66% |
| Dynam. Debt / Equity Ratio: | 778.14% |
Efficiency
| Employees: | 47,347 |
| Personal Expenses / Employee: | - JPY |
| Revenues / Employee: | 85,063,002.94 JPY |
| Net Income / Employee: | 6,695,609.01 JPY |
| Total Assets / Employee: | 294,796,924.83 JPY |
| * Fiscal Year End: | 3/31/2023 |
| Accounting Standard: | IFRS |
| Currency: | JPY |
